Kimia Biosciences (BOM:530313) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Kimia Biosciences's annualized Gross Profit for the quarter that ended in . 20 was ₹ Mil. Kimia Biosciences's average Total Assets over the quarter that ended in . 20 was ₹ 0 Mil. Therefore, Kimia Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Kimia Biosciences Gross-Profit-to-Asset % Historical Data

The historical data trend for Kimia Biosciences's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Gross-Profit-to-Asset % Chart

Kimia Biosciences Annual Data

Trend

Gross-Profit-to-Asset %

Kimia Biosciences Semi-Annual Data

Gross-Profit-to-Asset %

Competitive Comparison of Kimia Biosciences's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Gross-Profit-to-Asset % falls into.

Kimia Biosciences Gross-Profit-to-Asset % Calculation

Kimia Biosciences's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Kimia Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Kimia Biosciences Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines